Valuation: Vertex Pharmaceuticals Incorporated

Market Cap 134B 117B 108B 100B 190B 12,761B 193B 1,293B 502B 6,272B 503B 492B 21,615B P/E 2026 *
30.2x
P/E 2027 * 26.8x
Enterprise Value 121B 106B 97.4B 90.79B 172B 11,543B 175B 1,169B 455B 5,674B 455B 445B 19,553B EV / Sales 2026 *
9.3x
EV / Sales 2027 * 8.19x
Free-Float
99.8%
Yield 2026 *
-
Yield 2027 * -
1 day+6.03%
1 week+7.47%
Current month+6.30%
1 month+23.28%
3 months+20.36%
6 months+16.79%
Current year+16.47%
1 week 487.62
Extreme 487.62
529.14
1 month 433.8
Extreme 433.8
529.14
Current year 412.27
Extreme 412.27
529.14
1 year 362.5
Extreme 362.5
529.14
3 years 335.82
Extreme 335.82
529.14
5 years 176.36
Extreme 176.36
529.14
10 years 71.46
Extreme 71.46
529.14
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2020
Director of Finance/CFO 58 10/04/2019
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member 66 01/01/1998
Chairman 70 01/05/2012
Director/Board Member 57 18/06/2015
Date Insider Type Main position Quantity % Market Cap.
06-26Sell

Chief Technology Officer

-596 0.0002%
06-18Sell

Chief Technology Officer

-1,020 0.0004%
06-15Sell

Chief Technology Officer

-4,062 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+6.03%+7.47%+14.89%+51.92% 134B
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+32.57%+24.89% 338B
-0.56%+0.96%+41.67%+39.35% 299B
-0.08%+1.30%+32.15%+44.48% 291B
-1.54%+2.81%-25.35%-39.61% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +2.49%+5.12%+30.09%+57.59% 382.64B
Weighted average by Cap. +2.38%+5.69%+41.35%+82.21%

Financials

2026 *2027 *
Net sales 13.04B 11.4B 10.47B 9.76B 18.52B 1,241B 18.8B 126B 48.88B 610B 48.94B 47.89B 2,103B 14.27B 12.47B 11.46B 10.68B 20.26B 1,358B 20.57B 138B 53.49B 668B 53.55B 52.4B 2,301B
Net income 4.45B 3.89B 3.58B 3.33B 6.32B 424B 6.42B 42.93B 16.69B 208B 16.71B 16.35B 718B 5.05B 4.42B 4.06B 3.78B 7.18B 481B 7.29B 48.74B 18.95B 236B 18.97B 18.56B 815B
Net Debt -12.78B -11.18B -10.27B -9.57B -18.16B -1,217B -18.43B -123B -47.93B -598B -47.99B -46.96B -2,062B -17.13B -14.98B -13.77B -12.83B -24.34B -1,631B -24.71B -165B -64.24B -802B -64.32B -62.93B -2,763B
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
Date Price Change Volume
02/07/26 $528.04 +6.03% 1,855,943
01/07/26 $498.01 +0.26% 1,444,535
30/06/26 $496.73 -0.58% 1,738,335
29/06/26 $499.65 +1.69% 2,055,780
26/06/26 $491.34 +2.32% 8,693,047
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
528.04USD
Average target price
548.69USD
Spread / Average Target
+3.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VRTX Stock